CiVi Biopharma - Crunchbase Company Profile & Funding

Q: Who invested in CiVi Biopharma?

CiVi Biopharma has 4 investors including Boxer Capital And Roche Venture Fund.

Q: When was the last funding round for CiVi Biopharma?

CiVi Biopharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has CiVi Biopharma raised to date?

CiVi Biopharma has raised obfuscated.

Overview

CiVi Biopharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About CiVi Biopharma

CB Rank

61407

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

Founded

obfuscation

Private

Venture - Series Unknown

Chevy Chase, Maryland, United States

11-50

www.civibio.com/

Biotechnology

Clinical Trials

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Shalom Jacobovitz: CEO
Jess Thiersen: Co-Founder

Details

Legal Name

CiVi Biopharma Inc

Operating Status

Active

Company Type

For Profit

Founders

Henrik Orum, Jess Thiersen

About the Company

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular and metabolic therapies that have meaningful value to patients. The company has multiple assets in various stages of development including Intravenous Iloprost in Phase 3 trials for treatment of Systemic Sclerosis.

Phone Number

301-968-2390

Contact Email

info@civibio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CiVi 008

An oral antisense oligonucleotide targeting PCSK9 to reduce LDL cholesterol and prevent atherosclerotic cardiovascular disease.

CiVi 030

An intravenous formulation of iloprost for treating severe frostbite by vasodilation and platelet inhibition.

Research & Development

CiVi Biopharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - CiVi Biopharma	4	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Boxer Capital	—	Venture Round - CiVi Biopharma	—
Boxer Capital	—	Venture Round - CiVi Biopharma	—
Boxer Capital	—	Venture Round - CiVi Biopharma	—
Boxer Capital	—	Venture Round - CiVi Biopharma	—
Boxer Capital	—	Venture Round - CiVi Biopharma	—